These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22421338)

  • 1. The interleukin-6 pathway and atherosclerosis.
    Boekholdt SM; Stroes ES
    Lancet; 2012 Mar; 379(9822):1176-8. PubMed ID: 22421338
    [No Abstract]   [Full Text] [Related]  

  • 2. The interleukin 6 pathway and atherosclerosis.
    Scheller J; Rose-John S
    Lancet; 2012 Jul; 380(9839):338. PubMed ID: 22841333
    [No Abstract]   [Full Text] [Related]  

  • 3. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
    ; Swerdlow DI; Holmes MV; Kuchenbaecker KB; Engmann JE; Shah T; Sofat R; Guo Y; Chung C; Peasey A; Pfister R; Mooijaart SP; Ireland HA; Leusink M; Langenberg C; Li KW; Palmen J; Howard P; Cooper JA; Drenos F; Hardy J; Nalls MA; Li YR; Lowe G; Stewart M; Bielinski SJ; Peto J; Timpson NJ; Gallacher J; Dunlop M; Houlston R; Tomlinson I; Tzoulaki I; Luan J; Boer JM; Forouhi NG; Onland-Moret NC; van der Schouw YT; Schnabel RB; Hubacek JA; Kubinova R; Baceviciene M; Tamosiunas A; Pajak A; Topor-Madry R; Malyutina S; Baldassarre D; Sennblad B; Tremoli E; de Faire U; Ferrucci L; Bandenelli S; Tanaka T; Meschia JF; Singleton A; Navis G; Mateo Leach I; Bakker SJ; Gansevoort RT; Ford I; Epstein SE; Burnett MS; Devaney JM; Jukema JW; Westendorp RG; Jan de Borst G; van der Graaf Y; de Jong PA; Mailand-van der Zee AH; Klungel OH; de Boer A; Doevendans PA; Stephens JW; Eaton CB; Robinson JG; Manson JE; Fowkes FG; Frayling TM; Price JF; Whincup PH; Morris RW; Lawlor DA; Smith GD; Ben-Shlomo Y; Redline S; Lange LA; Kumari M; Wareham NJ; Verschuren WM; Benjamin EJ; Whittaker JC; Hamsten A; Dudbridge F; Delaney JA; Wong A; Kuh D; Hardy R; Castillo BA; Connolly JJ; van der Harst P; Brunner EJ; Marmot MG; Wassel CL; Humphries SE; Talmud PJ; Kivimaki M; Asselbergs FW; Voevoda M; Bobak M; Pikhart H; Wilson JG; Hakonarson H; Reiner AP; Keating BJ; Sattar N; Hingorani AD; Casas JP
    Lancet; 2012 Mar; 379(9822):1214-24. PubMed ID: 22421340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
    ; Sarwar N; Butterworth AS; Freitag DF; Gregson J; Willeit P; Gorman DN; Gao P; Saleheen D; Rendon A; Nelson CP; Braund PS; Hall AS; Chasman DI; Tybjærg-Hansen A; Chambers JC; Benjamin EJ; Franks PW; Clarke R; Wilde AA; Trip MD; Steri M; Witteman JC; Qi L; van der Schoot CE; de Faire U; Erdmann J; Stringham HM; Koenig W; Rader DJ; Melzer D; Reich D; Psaty BM; Kleber ME; Panagiotakos DB; Willeit J; Wennberg P; Woodward M; Adamovic S; Rimm EB; Meade TW; Gillum RF; Shaffer JA; Hofman A; Onat A; Sundström J; Wassertheil-Smoller S; Mellström D; Gallacher J; Cushman M; Tracy RP; Kauhanen J; Karlsson M; Salonen JT; Wilhelmsen L; Amouyel P; Cantin B; Best LG; Ben-Shlomo Y; Manson JE; Davey-Smith G; de Bakker PI; O'Donnell CJ; Wilson JF; Wilson AG; Assimes TL; Jansson JO; Ohlsson C; Tivesten Å; Ljunggren Ö; Reilly MP; Hamsten A; Ingelsson E; Cambien F; Hung J; Thomas GN; Boehnke M; Schunkert H; Asselbergs FW; Kastelein JJ; Gudnason V; Salomaa V; Harris TB; Kooner JS; Allin KH; Nordestgaard BG; Hopewell JC; Goodall AH; Ridker PM; Hólm H; Watkins H; Ouwehand WH; Samani NJ; Kaptoge S; Di Angelantonio E; Harari O; Danesh J
    Lancet; 2012 Mar; 379(9822):1205-13. PubMed ID: 22421339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial watch: Genetic association studies link interleukin-6 receptor to coronary heart disease.
    Harrison C
    Nat Rev Drug Discov; 2012 Apr; 11(5):342. PubMed ID: 22543459
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetically Proxied IL-6 Receptor Inhibition and Coronary Artery Disease Risk in a Japanese Population.
    Zhao SS; Gill D
    Clin Ther; 2024 Aug; 46(8):657-658. PubMed ID: 38821768
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-6: an antagonizing problem becomes a solution.
    Rettig MB
    Nat Biotechnol; 1997 Oct; 15(10):952-3. PubMed ID: 9335041
    [No Abstract]   [Full Text] [Related]  

  • 8. Devic disease: translational medicine at work.
    Rose-John S; Gold R
    Neurology; 2014 Apr; 82(15):1294-5. PubMed ID: 24634457
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of relapsing polychondritis with tocilizumab.
    Wendling D; Godfrin-Valnet M; Prati C
    J Rheumatol; 2013 Jul; 40(7):1232. PubMed ID: 23818726
    [No Abstract]   [Full Text] [Related]  

  • 10. Dr. Wallace and Dr. Stone reply.
    Wallace ZS; Stone JH
    J Rheumatol; 2013 Jul; 40(7):1232. PubMed ID: 23980261
    [No Abstract]   [Full Text] [Related]  

  • 11. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade.
    Wallace ZS; Stone JH
    J Rheumatol; 2013 Jan; 40(1):100-1. PubMed ID: 23280172
    [No Abstract]   [Full Text] [Related]  

  • 12. Tocilizumab (Actemra) for giant cell arteritis.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):161-162. PubMed ID: 28922343
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin 6 as therapeutic target in athero-/arteriosclerosis--small steps towards a new treatment paradigm in cardiovascular disease?
    Henry RM
    Atherosclerosis; 2011 Dec; 219(2):390-1. PubMed ID: 21840523
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-6 targeting therapy in familial Mediterranean fever.
    Fujikawa K; Migita K; Tsukada T; Umeda M; Nonaka F; Kawakami A; Eguchi K
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):150-1. PubMed ID: 24064027
    [No Abstract]   [Full Text] [Related]  

  • 15. The biology of interleukin-6 in the 21st century.
    Rose-John S
    Semin Immunol; 2014 Feb; 26(1):1. PubMed ID: 24556601
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.
    Akiyama M; Yasuoka H; Takeuchi T
    Ann Hematol; 2017 Dec; 96(12):2117-2119. PubMed ID: 28861599
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Schinnerling K; Aguillón JC; Catalán D; Soto L
    Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis.
    Nakamura I; Omata Y; Naito M; Ito K
    J Rheumatol; 2009 Feb; 36(2):459-60. PubMed ID: 19208585
    [No Abstract]   [Full Text] [Related]  

  • 19. Is interleukin-6 circulating levels associated with coronary artery disease?
    Liu C
    Int J Cardiol; 2012 May; 157(2):270; author reply 253-4. PubMed ID: 22456261
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.
    Tanaka T; Narazaki M; Kishimoto T
    FEBS Lett; 2011 Dec; 585(23):3699-709. PubMed ID: 21419125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.